Intuitive Surgical (ISRG) Earning Somewhat Positive News Coverage, Accern Reports
Media coverage about Intuitive Surgical (NASDAQ:ISRG) has been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Intuitive Surgical earned a news sentiment score of 0.20 on Accern’s scale. Accern also gave media coverage about the medical equipment provider an impact score of 46.376894992069 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Here are some of the news headlines that may have effected Accern’s analysis:
- Who is showing interest in Intuitive Surgical, Inc. (ISRG) stock Buyer or Seller? – Wall Street Morning (wallstreetmorning.com)
- Comparing Intuitive Surgical (ISRG) and Pulse Biosciences (PLSE) (americanbankingnews.com)
- Intuitive Surgical, Inc. (ISRG) – Technical in Focus – Wall Street Morning (wallstreetmorning.com)
- Analyzing Accelerate Diagnostics (AXDX) & Intuitive Surgical (ISRG) (americanbankingnews.com)
- Intuitive Surgical (ISRG) Upgraded by Vetr to Strong-Buy (americanbankingnews.com)
A number of analysts recently commented on ISRG shares. Zacks Investment Research upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $409.00 target price for the company in a research note on Wednesday, January 3rd. BidaskClub cut shares of Intuitive Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, December 12th. Goldman Sachs Group reiterated a “buy” rating on shares of Intuitive Surgical in a research note on Saturday, November 18th. Vetr upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating and set a $434.75 target price for the company in a research note on Monday, January 8th. Finally, Stifel Nicolaus reiterated a “buy” rating and issued a $480.00 target price (up from $400.00) on shares of Intuitive Surgical in a research note on Thursday, January 25th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $408.48.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, January 25th. The medical equipment provider reported $2.54 EPS for the quarter, beating the consensus estimate of $2.27 by $0.27. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The business had revenue of $892.40 million during the quarter, compared to analysts’ expectations of $866.54 million. During the same period in the previous year, the business posted $2.03 EPS. The business’s quarterly revenue was up 17.9% compared to the same quarter last year. sell-side analysts forecast that Intuitive Surgical will post 7.93 earnings per share for the current year.
In other Intuitive Surgical news, EVP Curet Myriam sold 262 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 30th. The shares were sold at an average price of $431.50, for a total transaction of $113,053.00. Following the completion of the sale, the executive vice president now directly owns 2,152 shares in the company, valued at approximately $928,588. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Mark J. Rubash sold 6,000 shares of Intuitive Surgical stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $395.95, for a total transaction of $2,375,700.00. Following the sale, the director now owns 5,453 shares of the company’s stock, valued at $2,159,115.35. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 85,016 shares of company stock valued at $35,133,026. Company insiders own 2.20% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://theolympiareport.com/2018/02/14/intuitive-surgical-isrg-earning-somewhat-positive-news-coverage-accern-reports.html.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.